TP53 and p53 statuses and their clinical impact in diffuse low grade gliomas.
about
Molecular characteristics of pediatric high-grade gliomas5-hydroxymethylcytosine loss is associated with poor prognosis for patients with WHO grade II diffuse astrocytomas.Not all 1p/19q non-codeleted oligodendroglial tumors are astrocytic.Pathology and genetics of diffuse gliomas in adults.Prediction of Response to Temozolomide in Low-Grade Glioma Patients Based on Tumor Size Dynamics and Genetic Characteristics.MRI features predict p53 status in lower-grade gliomas via a machine-learning approach.
P2860
TP53 and p53 statuses and their clinical impact in diffuse low grade gliomas.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
TP53 and p53 statuses and their clinical impact in diffuse low grade gliomas.
@en
TP53 and p53 statuses and their clinical impact in diffuse low grade gliomas.
@nl
type
label
TP53 and p53 statuses and their clinical impact in diffuse low grade gliomas.
@en
TP53 and p53 statuses and their clinical impact in diffuse low grade gliomas.
@nl
prefLabel
TP53 and p53 statuses and their clinical impact in diffuse low grade gliomas.
@en
TP53 and p53 statuses and their clinical impact in diffuse low grade gliomas.
@nl
P2093
P2860
P1476
TP53 and p53 statuses and their clinical impact in diffuse low grade gliomas.
@en
P2093
Agusti Alentorn
Amélie Liou
Brahima Doukouré
Emeline Gillet
Emeline Mundwiller
Hinke F van Thuijl
Jaap C Reijneveld
Jean-Yves Delattre
José Alfonso Meza Medina
Karima Mokhtari
P2860
P2888
P304
P356
10.1007/S11060-014-1407-4
P50
P577
2014-03-04T00:00:00Z
P5875
P6179
1046986563